Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Longer diazepam use may curb alcohol relapse

NCT ID NCT02242955

Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving people with alcohol dependence a one-month course of diazepam (40 mg per day) after detoxification could reduce the chance of relapsing into drinking within the next three months. The standard detoxification treatment is usually about one week. The idea was that longer treatment might ease lingering anxiety that often leads to relapse. The study enrolled 26 adults who had already started detoxification.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
diazepam
What this could lead to
If it works, this could point toward a longer treatment approach to help prevent early alcohol relapse after detoxification.
What could go wrong
This is a very small, early-phase study with only 26 participants, so results may not apply broadly. The extended diazepam use also carries risks like dependence and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Start date

Jul 2014

Finished

Jul 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * DSM-IV-Tr criteria for alcohol dependence * Diazepam-based outpatient detoxification procedure started 5 days prior to inclusion Exclusion Criteria: * contraindication for outpatient detoxification * occurrence of delirium tremens or seizures during the pre-inclusion period * contraindication for using diazepam * any other DSM-IV-TR criteria for substance abuse or dependence in the preceding year (except from tobacco) * concurrent axis-I psychiatric disorder * concurrent neurological pathology or cognitive impairment * concurrent social risk, i.e., homelessness or social isolation * liver failure, cancer, or significant breathing disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol dependence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse alcohol dependence anxiety disorder Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcoholism

Contacts and locations

Locations

  • Department of Addiction Medicine

    Lille, 59037, France

  • Outpatient Addiction Center "CSAPA - Le Pari"

    Lille, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.